Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Antioxidants can inhibit atherosclerosis in animals, though it is not clear whether this is due to the inhibition of aortic lipoprotein lipid (per)oxidation. Coantioxidants inhibit radical‐induced, tocopherol‐mediated peroxidation of lipids in lipoproteins through elimination of tocopheroxyl radical. Here we tested the effect of the bisphenolic probucol metabolite and coantioxidant H 212/43 on atherogenesis in apolipoprotein E and low density lipoprotein (LDL) receptor gene double knockout (apoE‐/‐;LDLr‐/‐) mice, and how this related to aortic lipid (per)oxidation measured by specific HPLC analyses. Dietary supplementation with H 212/43 resulted in circulating drug levels of ∼200 µM, increased plasma total cholesterol slightly and decreased plasma and aortic α‐tocopherol significantly relative to age‐matched control mice. Treatment with H 212/43 increased the antioxidant capacity of plasma, as indicated by prolonged inhibition of peroxyl radical‐induced, ex vivo lipid peroxidation. Aortic tissue from control apoE‐/‐;LDLr‐/‐ mice contained lipid hydro(pero)xides and substantial atherosclerotic lesions, both of which were decreased strongly by supplementation of the animals with H 212/43. The results show that a coantioxidant effectively inhibits in vivo lipid peroxidation and atherosclerosis in apoE‐/‐;LDLr‐/‐ mice, consistent with though not proving a causal relationship between aortic lipoprotein lipid oxidation and atherosclerosis in this model of the disease.—Witting, P. K., Pettersson, K., Östlund‐Lindqvist, A.‐M., Westerlund, C., Westin Eriksson, A., Stocker, R. Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice. FASEB J. 13, 667–675 (1999)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., & Maeda, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4471 · Cited by 944 · cited 1×
“ApoE2/2 mice, originally from a strain developed by Maeda and co-workers ( 32 ), were back-crossed six times to C57BL/6J mice.”
BackgroundIshibashi, S., Herz, J., Maeda, N., Goldstein, J. L., & Brown, M. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4431 · Cited by 430 · cited 1×
“LDLr2/2 mice were from a strain developed by Goldstein and co-workers (33).”
Walldius, G., Erikson, U., Olsson, A. G., Bergstrand, L., Hådell, K., Johansson, J., Kaijser, L., Lassvik, C., Mölgaard, J., Nilsson, S., et al. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90579-7 · Cited by 248 · cited 1×
“In humans, probucol is poorly metabolized into H 212/43 and has failed to reduce femoral atherosclerosis (44).”
Background
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Self-citationThe oxidative modification hypothesis of atherogenesis: an overview
Chisolm, G. M., & Steinberg, D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00344-0 · Cited by 746
Animal models of atherosclerosis
Emini Veseli, B., Perrotta, P., De Meyer, G. R. A., Roth, L., Van der Donckt, C., Martinet, W., & De Meyer, G. R. Y. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.010 · Cited by 548
The Oxidative Modification Hypothesis of Atherosclerosis Does It Hold for Humans?
Witztum, J. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00111-6 · Cited by 440
den Hartigh, L. (2019) · Nutrients · doi:10.3390/nu11020370 · Cited by 371
“Double apoE-/-Ldlr-/- mice develop comparable levels of hypercholesterolemia and lipoprotein profiles as apoE-/- mice [170], but with more extensive atherosclerosis that more closely resemble human plaques [171].”
Background
Metadata
- Authors
- Witting, P. K., Pettersson, K., Östlund-Lindqvist, A.-M., Westerlund, C., Eriksson, A. W., & Stocker, R.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1999-04
- Volume
- 13
- Issue
- 6
- Pages
- 667-675
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1509142633
- Cited by
- 98
- References
- 3
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.